Incidental cause of mild hyperglycemia in children: Genetic, clinical, and follow-up features of glucokinase-MODY diabetes
Küçük Resim Yok
Tarih
2023
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Aim: This study aimed to present the genetic, clinical, and follow-up data of our pa- tients diagnosed with glucokinase (GCK)-MODY. Type 2 Maturity Onset Diabetes of the Young (MODY) is a monogenic disease characterized by fasting hyperglycemia resulting from impaired insulin secretion. It constitutes the vast majority of cases with monogenic diabetes. Materials and Methods: In the study, clinical, follow-up, and genetic data of 13 patients who were followed up with the diagnosis of MODY type 2 diabetes and had mutations in the GCK gene in their molecular analyses were studied. GCK whole gene sequence analysis was performed with Sanger sequencing. Results: The age at diagnosis was median 11.0 years (range: 2.5–16.9). High blood sugar was the most common reason for admission (84.6%). At the time of diagnosis, the patients’ mean blood sugar was 137.0±52.4 mg/dL, insulin 6.1±2.8 mU/L, c-peptide 1.4±0.6 ng/mL, triglyceride 106.1±42.3 mg/dL, and cholesterol 154.0±19.0 mg/dL. While HbA1c was 6.3±0.4 at the time of diagnosis, it was 6.2±0.4 at the end of the mean 5-year follow-up (p=0.073). Molecular analysis revealed the most common variant as c.565A>G (p.I189Val) (53.8%). In all cases, glucose levels were regulated by diet and exercise, and there was no need for insulin. Conclusion: Incidental blood glucose elevation was an important finding in diagnosing GCK-MODY. With the molecular diagnosis of these patients, clinical follow-ups, treat- ment plans, and long-term prognoses can be planned more accurately. Therefore, in doubtful cases, the genetic diagnosis should be confirmed by sequencing the GCK gene.
Açıklama
Anahtar Kelimeler
Kaynak
Annals of Medical Research
WoS Q Değeri
Scopus Q Değeri
Cilt
30
Sayı
2
